SmPC - Methofill 50mg/ml solution for injection in pre-filled syringe: Change history
View Summary of Product Characteristics (SmPC - Methofill 50mg/ml solution for injection in pre-filled syringe)
Last updated on this site: 27 Jun 2024
Update to SmPC section 6.5 and leaflet section 6 to remove without blister packaging details
Last updated on this site: 27 Jun 2024
Update to SmPC section 6.5 and leaflet section 6 to remove without blister packaging details
-
Changes: (Updated: 27 Jun 2024)
Update to SmPC section 6.5 and leaflet section 6 to remove without blister packaging details
-
Changes: (Updated: 18 Dec 2023)
Description of update: Type IB (C.I.3.a) variation application to update section 4.6 of SmPC and to update section 2 of PIL in-line with the agreed wording of PSUFU (DE/H/PSUFU/00002014/202110) for Injexate 50 mg/ml solution for injection in pre-filled syringe.
SmPC Sections updated: 4.6 and 10.
-
Changes: (Updated: 17 Mar 2023)
Reupload to amend .pdf title (no change to SmPC contents)
-
Changes: (Updated: 10 Jan 2023)
Variation update: Update the ATC Code for “Methotrexate” as published by WHO for Injexate 50 mg/ml solution for injection in pre-filled syringe.
SmPC sections updated: 5.1 & 10.
-
Changes: (Updated: 20 Sep 2022)
Linked to amended product entry
-
Changes: (Updated: 15 Sep 2022)
Initial upload